The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Storm Ewan gives a wet and windy end to the weekend across many northern and western areas.
The Home Secretary said the Government is "against cliff edges" and immigration figures will not suddenly fall when the UK leaves the EU.
Peter Whittle has said it was probably too early for Paul Nuttall to run as an MP for the party after only just becoming its leader.